Daniel Lu
Impact in
-
- Liver physiology and pathology
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- RNA modifications and cancer 2
- Signaling Pathways in Disease 1
- Protein Degradation and Inhibitors 1
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- William W. Lockwood (8 shared papers)Romel Somwar (5 shared papers)Michael Offin (2 shared papers)Charles M. Rudin (2 shared papers)Ken Suzawa (2 shared papers)Alexander Drilon (2 shared papers)Maria E. Arcila (2 shared papers)Marc Ladanyi (3 shared papers)
- Journals
- Cancers (2 papers)Clinical Cancer Research (1 paper)The Journal of Immunology (1 paper)Journal of Thoracic Oncology (1 paper)Oncogenesis (1 paper)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
Daniel Lu
10 papers receiving 217 citations
Peers
Comparison fields: 5 of 39
- Hepatology 50
- Genetics 33
- Pulmonary and Respiratory Medicine 101
- Pathology and Forensic Medicine 52
- Hematology 28
Countries citing papers authored by Daniel Lu
This map shows the geographic impact of Daniel Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lu more than expected).
Fields of papers citing papers by Daniel Lu
This network shows the impact of papers produced by Daniel Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lu. The network helps show where Daniel Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 83 | |
| 2 | 2019 | 41 | |
| 3 | 2018 | 37 | |
| 4 | 2021 | 22 | |
| 5 | 2018 | 14 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 7 | |
| 8 | 2015 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 0 |
About Daniel Lu
Daniel Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Hematology, having authored 11 papers that have together received 218 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Chronic Lymphocytic Leukemia Research (2 papers), RNA modifications and cancer (2 papers), Cancer Genomics and Diagnostics (1 paper), Signaling Pathways in Disease (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Hepatology (50 citations), Genetics (33 citations), Pulmonary and Respiratory Medicine (101 citations), Pathology and Forensic Medicine (52 citations) and Hematology (28 citations). Daniel Lu has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include William W. Lockwood, Romel Somwar, Michael Offin, Charles M. Rudin, Ken Suzawa, Alexander Drilon, Maria E. Arcila, Marc Ladanyi, Inna Khodos and Danelle F. James. Their work appears in journals such as Cancers, Clinical Cancer Research, The Journal of Immunology, Journal of Thoracic Oncology and Oncogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.